Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Revance Therapeutics (RVNC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2015	09-2015	06-2015	03-2015	12-2014
Assets
Current Assets
Cash & Cash Equivalents	201,650	90,529	96,452	153,752	171,107
Marketable Securities	50,688	51,364	38,884	N/A	N/A
TOTAL	$253,963	$143,497	$137,256	$155,689	$172,731

Non-Current Assets
PPE Net	19,708	19,254	19,134	19,390	19,274
Investments And Advances	1,751	2,357	14,052	0	0
Other Non-Current Assets	400	406	774	643	464
TOTAL	$21,859	$22,017	$33,960	$20,033	$19,738

Total Assets	$275,822	$165,514	$171,216	$175,722	$192,469

Liabilities
Current Liabilities
Short Term Debt	3,135	3,018	2,906	319	2,942
Accounts payable and accrued liabilities	2,657	2,731	2,211	2,089	3,149
Accrued Expenses	6,245	5,990	5,040	4,019	4,145
TOTAL	$12,037	$11,739	$10,157	$6,427	$10,236

Non-Current Liabilities
Long Term Debt	5,346	6,176	6,973	513	598
Other Non-Current Liabilities	1,414	1,481	1,494	1,583	1,541
TOTAL	$10,533	$11,419	$12,218	$5,837	$5,864

Total Liabilities	$22,570	$23,158	$22,375	$12,264	$16,100

Shareholders' Equity
Shares Outstanding, K	28,433	28,062	23,951	23,947	23,935
Common Shares	28	24	24	24	24
Retained earnings	-332,273	-310,179	-291,004	-274,199	-258,797
Other shareholders' equity	-40	10	-12	0	0
TOTAL	$253,252	$142,356	$148,841	$163,458	$176,369

Total Liabilities And Equity	$275,822	$165,514	$171,216	$175,722	$192,469